Prosecution Insights
Last updated: April 19, 2026

Astellas Gene Therapies, Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18039812 RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING MYOTONIC DYSTROPHY TYPE 1 VIJAYARAGHAVAN, JAGAMYA NMN 1633 Non-Final OA Jun 01, 2023
17771627 COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISORDERS NOBLE, MARCIA STEPHENS 1632 Final Rejection Apr 25, 2022

Managing Astellas Gene Therapies, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month